Canakinumab: In patients with cryopyrin-associated periodic syndromes

BioDrugs

Volumn 26, Issue 1, 2012, Pages 53-59

  Curran, Monique P ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

Adis Drug Profiles; Canakinumab; Cryopyrin associated Periodic syndromes

Indexed keywords

CANAKINUMAB;

ABDOMINAL ABSCESS; ABDOMINAL PAIN; AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; BACKACHE; BILIRUBIN BLOOD LEVEL; BRONCHITIS; CINCA SYNDROME; COUGHING; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; HEADACHE; HUMAN; INFECTION; INJECTION SITE REACTION; LIMB PAIN; MOUTH PAIN; MUCKLE WELLS SYNDROME; NAUSEA; PHARMACODYNAMICS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REMISSION; REVIEW; RHINITIS; RHINOPHARYNGITIS; SIDE EFFECT; SINGLE DRUG DOSE; SORE THROAT; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VERTIGO; VIRUS INFECTION; VOMITING;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; HUMANS; INTERLEUKIN-1BETA;

EID: 84855674769     PISSN: 11738804     EISSN: 1179190X     Source Type: Journal    
DOI: 10.2165/11208450-000000000-00000     Document Type: Review

References (16)

1. Toker O, Hashkes PJ. Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS). Biologics 2010; 4: 131-8
2. Kubota T, Koike R. Cryopyrin-associated periodic syndromes: background and therapeutics. Mod Rheumatol 2010 Jun; 20 (3): 213-21
3. Cuisset L, Jeru I, Dumont B, et al. Mutations in the autoinflammatory cryopyrin- associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis 2011 Mar; 70 (3): 495-9
4. Yu JR, Leslie KS. Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response. Curr Allergy Asthma Rep 2011 Feb; 11 (1): 12-20
5. Lachmann HJ, Quartier P, So A, et al. The emerging role of interleukin-1b in autoinflammatory diseases. Arthritis Rheum 2011 Feb; 63 (2): 314-24
6. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011; 117 (14): 3720-32
7. European Medicines Agency. Ilaris- (canakinumab powder for solution for injection): summary of product characteristics [online]. Available from URL: http://www.ema.europa.eu [Accessed 2011 Nov 22]
8. Ilaris-(canakinumab) injection for subcutaneous use: US prescribing information. East Hanover (NJ): Novartis Pharmaceuticals Corporation, 2009
9. Ilaris- (canakinumab 150 mg) for subcutaneous injection: Japanese prescribing information. Tokyo: Novartis Pharma K.K., 2011
10. Lachmann HJ, Lowe P, Felix SD, et al. In vivo regulation of interleukin 1b in patients with cryopyrin-associated periodic syndromes. J Exp Med 2009 May 11; 206 (5): 1029-36
11. Church LD, McDermott MF. Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders. Curr Opin Mol Ther 2009; 11 (1): 81-9
12. Alten R, Gram H, Joosten LA, et al. The human anti-IL-1b monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Res Ther 2008; 10 (3): R67
13. Church LD, McDermott MF. Canakinumab: A human anti-IL-1bmonoclonal antibody for the treatment of cryopyrin-associated periodic syndromes. Expert Rev Clin Immunol 2010 Nov; 6 (6): 831-41
14. Kuemmerle-Deschner JB, Hachulla E, Cartwright R, et al. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. Ann Rheum Dis 2011 Dec; 70 (12): 2095-102
15. Kuemmerle-Deschner JB, Ramos E, Blank N, et al. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1b mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS). Arthritis Res Ther 2011 Feb 28; 13 (1): R34
16. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009 Jun 4; 360 (23): 2416-25